One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Physician Dispensed Cosmeceuticals Market

[ 英語タイトル ] Physician Dispensed Cosmeceuticals Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0089144
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 113
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Abbvie Inc (Allergan PLC)
- Merz Pharma
- Innovative Skincare
- Obagi Cosmeceuticals LLC
- SkinCeuticals International
- Cuskin.
- Khiron Life Sciences Corp
- La Roche-Posay

[Report Description]

The Physician Dispensed Cosmeceuticals are the custom made products that penetrate deeper into the skin than the normal OTC products. As these products are deeply penetrated, it provides early and better results which is the prime factor responsible for the growth of this market.

Most Physician lines are designed and formulated by the physicians, skin professionals and scientists who have researched ingredients for many years and put them into action in their own practices to treat intended targets. Additionally, increasing importance on the beauty and appearance, growing awareness about anti-aging, and increasing awareness about the safety and efficacy of physician-dispensed cosmeceuticals are the other factors that are contributing to the growth of the market.

Moreover, several local dermatologists owned professional startups specializing in the cosmeceuticals have rapidly entered into the market which is catering to the growth of the market by driving the demand for the usage of physician-dispensed cosmeceuticals among localities.

Key Market Trends

Anti-Ageing Segment Holds a Significant Market Share During the Forecast Period

Consumers, especially the aging population, are increasingly looking for methods and products to maintain and improve their appearance to look youthful and beautiful, more so with the rising awareness about anti-aging products.

The middle-aged people are increasingly witnessing aging anxiety, due to the high prevalence of extrinsic signs of aging. Anti-aging skin products are known as cosmeceuticals, as they overlap the distinction between cosmetics and pharmaceuticals.

Obagi Nu-Derm System from Obagi Cosmeceuticals LLC is a Wide-ranging skincare product especially formulated for normal to dry skin to help to correct hyperpigmentation and transform the appearance of aging skin. Hence all these factors are expected to drive the overall market.

Asia Pacific is the Fastest Growing Region in Physician Dispensed Cosmeceuticals Market

The market in the Asia Pacific region is expected to grow significantly over the forecast period. Growing preference to be hold long-lasting youthful appearance and beauty is driving the demand for effective physician-dispensed cosmeceuticals in the region. Furthermore, the growing focus of key market players on expansion in Asia Pacific countries, the huge customer base in the region, and rising awareness about physician-dispensed cosmeceuticals will also drive the market in the Asia Pacific.

Competitive Landscape

The market is moderately competitive due to the presence of many small and large manufacturers. competition in the market is high due to the increasing investments in R&D for product innovation and increasing efficiency of the product by launching new products into the market. Key market players in the respective market are Allergan, Merz Pharma, INNOVATIVE SKINCARE, Obagi Cosmeceuticals LLC, SkinCeuticals International amongst others.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Beauty Consciousness
4.2.2 Growing Awareness About Physician Dispensed Cosmeceuticals
4.3 Market Restraints
4.3.1 High Cost of the Products
4.3.2 Lack of Trained and Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Skin Care Anti-Ageing Sunscreens Other Skin Care Products
5.1.2 Eye Care Prescription Drops Artificial Tears Other Eye Care Products
5.1.3 Hair Care Hair Repair Anti-dandruff Other Hair care Products
5.1.4 Others
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.2.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Abbvie Inc (Allergan PLC)
6.1.2 Merz Pharma
6.1.3 Innovative Skincare
6.1.4 Obagi Cosmeceuticals LLC
6.1.5 SkinCeuticals International
6.1.6 Cuskin.
6.1.7 Khiron Life Sciences Corp
6.1.8 La Roche-Posay




Recommended reports